OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid Lowering Drugs: Present Status and Future Developments
Massimiliano Ruscica, Nicola Ferri, Raúl D. Santos, et al.
Current Atherosclerosis Reports (2021) Vol. 23, Iss. 5
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Jan Borén, Marja‐Riitta Taskinen, Elias Björnson, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 9, pp. 577-592
Closed Access | Times Cited: 151

The Multifaceted Biology of PCSK9
Nabil G. Seidah, Annik Prat
Endocrine Reviews (2021) Vol. 43, Iss. 3, pp. 558-582
Open Access | Times Cited: 148

Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases
Atena Mansouri, Željko Reiner, Massimiliano Ruscica, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1313-1313
Open Access | Times Cited: 94

Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tahmineh Kandelouei, Mitra Abbasifard, Danyal Imani, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 84

Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor
Ajit Regmi, Eitaro Aihara, Michael E. Christe, et al.
Cell Metabolism (2024) Vol. 36, Iss. 7, pp. 1534-1549.e7
Open Access | Times Cited: 27

The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury
Abigail R. Bland, Fergus M. Payne, John C. Ashton, et al.
Pharmacological Research (2021) Vol. 175, pp. 105986-105986
Closed Access | Times Cited: 60

Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
Nicola Ferri, Massimiliano Ruscica, Sergio Fazio, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 943-943
Open Access | Times Cited: 15

PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
Stefano Carugo, Cesare R. Sirtori, Alberto Corsini, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 12, pp. 995-1004
Open Access | Times Cited: 31

Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities
Zi‐Han Yang, Fangzhou Chen, Yixiang Zhang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 8

Differences in Stable and Unstable Atherosclerotic Plaque
Kenji Kawai, Rika Kawakami, Aloke V. Finn, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 7, pp. 1474-1484
Closed Access | Times Cited: 7

Unveiling Familial Hypercholesterolemia—Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy
Piotr Fularski, Joanna Hajdys, Gabriela Majchrowicz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1637-1637
Open Access | Times Cited: 5

Hypertriglyceridemia Therapy: Past, Present and Future Perspectives
Ileana Canfora, Sabata Pierno
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9727-9727
Open Access | Times Cited: 5

Therapeutic effects of statins on osteoarthritis: A review
Shirin Saberianpour, Samaneh Abolbashari, Mohamad Hadi Saeed Modaghegh, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 8, pp. 1285-1297
Open Access | Times Cited: 20

Statin associated muscle symptoms: An update and review
Weston Dicken, Anurag Mehta, Angelos Karagiannis, et al.
Progress in Cardiovascular Diseases (2022) Vol. 75, pp. 40-48
Closed Access | Times Cited: 19

Updates in Small Interfering RNA for the Treatment of Dyslipidemias
Stefano Carugo, Cesare R. Sirtori, Guido Gelpi, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 11, pp. 805-817
Open Access | Times Cited: 12

Nanozymes: A novel approach to upgrade atherosclerosis treatment
Maryam Mahjoubin‐Tehran, Prashant Kesharwani, Wael Alamahmeed, et al.
Pathology - Research and Practice (2025), pp. 156005-156005
Closed Access

Pleiotropic properties of statins via angiogenesis modulation in cardiovascular disease
Fatemeh Zahedipour, Alexandra E. Butler, Ali H. Eid, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103325-103325
Open Access | Times Cited: 15

Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study
Roberto Pontremoli, Giovambattista Desideri, Marcello Arca, et al.
European Journal of Internal Medicine (2023) Vol. 111, pp. 90-96
Open Access | Times Cited: 8

Efficacy and Safety of Lipid-Lowering Drugs of Different Intensity on Clinical Outcomes: A Systematic Review and Network Meta-Analysis
Wenrui Ma, Qinyuan Pan, Defeng Pan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 19

Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis
Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 18

Cardiovascular prevention in elderly patients.
Clara Bonanad, Rosa Fernández-Olmo, Sergio García‐Blas, et al.
PubMed (2022) Vol. 19, Iss. 5, pp. 377-392
Closed Access | Times Cited: 13

Page 1 - Next Page

Scroll to top